BioCentury | Apr 21, 2017
Emerging Company Profile

Orchard’s pickings

...Los Angeles, University of Manchester ; Boston Children’s Hospital Corporate partners: Oxford Biomedica plc , PharmaCell B.V....
BioCentury | May 5, 2016
Product R&D

Cell therapy's yada yada yada

..."eats doses," he said. However, Nasser Sadr, manager of process development and research at CMO PharmaCell B.V....
...Bethesda, Md. New WuXi Life Science Ltd., Shanghai, China Novartis AG (NYSE:NVS; SIX:NOVN), Basel, Switzerland PharmaCell B.V....
BioCentury | Jun 9, 2014
Company News

PharmaCell B.V., TiGenix deal

...TiGenix's cGMP cell therapy production facility for €5.8 million ($7.8 million) (see BioCentury, Feb. 3). PharmaCell B.V....
BioCentury | Feb 3, 2014
Company News

PharmaCell, TiGenix deal

...PharmaCell will purchase TiGenix's cGMP cell therapy production €5.8 million ($7.9 million). PharmaCell will also acquire...
...$4.8 million) up front and a final payment of €750,000 ($1 million) after three years. PharmaCell...
...€2.3 million ($3 million) in ChrondoCelect sales for the six months ended June 30, 2013. PharmaCell B.V....
BioCentury | Nov 4, 2013
Company News

Dendreon, PharmaCell deal

...The companies declined to disclose details (see BioCentury, Sept. 23). Dendreon Corp. (NASDAQ:DNDN), Seattle, Wash. PharmaCell B.V....
BioCentury | Mar 9, 2009
Company News

Alloksys, Cevec, PharmaCell deal

...and produce the cell line and Alloksys will conduct preclinical and clinical testing. Cevec and PharmaCell...
...IP. Alloksys Life Sciences B.V. , Bunnik, the Netherlands Cevec Pharmaceuticals GmbH , Cologne, Germany PharmaCell B.V....
BioCentury | Oct 1, 2007
Company News

Dutch Ministry of Economic Affairs cardiovascular, cancer, musculoskeletal news

...Euronext:PHI; PHG, Eindhoven, the Netherlands). Biotech companies Pharming Group N.V. (Euronext:PHARM, Leiden, the Netherlands) and Pharmacell B.V....
BioCentury | Jun 12, 2006
Company News

CyGenics, PharmaCell deal

...CYN purchased a 20% stake in PharmaCell for an undisclosed amount of cash. In exchange, CYN...
...for an undisclosed amount of cash. In exchange, CYN said it will have access to PharmaCell's...
...manufacture cell therapy products. CYN, which has an option to acquire the remaining 80% of PharmaCell...
Items per page:
1 - 8 of 8
BioCentury | Apr 21, 2017
Emerging Company Profile

Orchard’s pickings

...Los Angeles, University of Manchester ; Boston Children’s Hospital Corporate partners: Oxford Biomedica plc , PharmaCell B.V....
BioCentury | May 5, 2016
Product R&D

Cell therapy's yada yada yada

..."eats doses," he said. However, Nasser Sadr, manager of process development and research at CMO PharmaCell B.V....
...Bethesda, Md. New WuXi Life Science Ltd., Shanghai, China Novartis AG (NYSE:NVS; SIX:NOVN), Basel, Switzerland PharmaCell B.V....
BioCentury | Jun 9, 2014
Company News

PharmaCell B.V., TiGenix deal

...TiGenix's cGMP cell therapy production facility for €5.8 million ($7.8 million) (see BioCentury, Feb. 3). PharmaCell B.V....
BioCentury | Feb 3, 2014
Company News

PharmaCell, TiGenix deal

...PharmaCell will purchase TiGenix's cGMP cell therapy production €5.8 million ($7.9 million). PharmaCell will also acquire...
...$4.8 million) up front and a final payment of €750,000 ($1 million) after three years. PharmaCell...
...€2.3 million ($3 million) in ChrondoCelect sales for the six months ended June 30, 2013. PharmaCell B.V....
BioCentury | Nov 4, 2013
Company News

Dendreon, PharmaCell deal

...The companies declined to disclose details (see BioCentury, Sept. 23). Dendreon Corp. (NASDAQ:DNDN), Seattle, Wash. PharmaCell B.V....
BioCentury | Mar 9, 2009
Company News

Alloksys, Cevec, PharmaCell deal

...and produce the cell line and Alloksys will conduct preclinical and clinical testing. Cevec and PharmaCell...
...IP. Alloksys Life Sciences B.V. , Bunnik, the Netherlands Cevec Pharmaceuticals GmbH , Cologne, Germany PharmaCell B.V....
BioCentury | Oct 1, 2007
Company News

Dutch Ministry of Economic Affairs cardiovascular, cancer, musculoskeletal news

...Euronext:PHI; PHG, Eindhoven, the Netherlands). Biotech companies Pharming Group N.V. (Euronext:PHARM, Leiden, the Netherlands) and Pharmacell B.V....
BioCentury | Jun 12, 2006
Company News

CyGenics, PharmaCell deal

...CYN purchased a 20% stake in PharmaCell for an undisclosed amount of cash. In exchange, CYN...
...for an undisclosed amount of cash. In exchange, CYN said it will have access to PharmaCell's...
...manufacture cell therapy products. CYN, which has an option to acquire the remaining 80% of PharmaCell...
Items per page:
1 - 8 of 8